IL105569A - Pharmaceutical compositions containing remacemide for the treatment of parkinson's disease - Google Patents
Pharmaceutical compositions containing remacemide for the treatment of parkinson's diseaseInfo
- Publication number
- IL105569A IL105569A IL105569A IL10556993A IL105569A IL 105569 A IL105569 A IL 105569A IL 105569 A IL105569 A IL 105569A IL 10556993 A IL10556993 A IL 10556993A IL 105569 A IL105569 A IL 105569A
- Authority
- IL
- Israel
- Prior art keywords
- remacemide
- parkinson
- disease
- treatment
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929209599A GB9209599D0 (en) | 1992-05-02 | 1992-05-02 | Novel therapy for the treatment of parkinsons disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL105569A0 IL105569A0 (en) | 1993-08-18 |
| IL105569A true IL105569A (en) | 1997-11-20 |
Family
ID=10714969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105569A IL105569A (en) | 1992-05-02 | 1993-04-30 | Pharmaceutical compositions containing remacemide for the treatment of parkinson's disease |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0637956B1 (fr) |
| JP (1) | JP3542801B2 (fr) |
| KR (1) | KR950701216A (fr) |
| AT (1) | ATE181669T1 (fr) |
| CA (1) | CA2134783C (fr) |
| DE (1) | DE69325512T2 (fr) |
| DK (1) | DK0637956T3 (fr) |
| ES (1) | ES2135476T3 (fr) |
| GB (1) | GB9209599D0 (fr) |
| GR (1) | GR3031320T3 (fr) |
| HU (1) | HU211305A9 (fr) |
| IL (1) | IL105569A (fr) |
| NZ (2) | NZ252728A (fr) |
| SG (1) | SG49202A1 (fr) |
| WO (1) | WO1993021910A1 (fr) |
| ZA (1) | ZA933086B (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025369A (en) * | 1996-05-03 | 2000-02-15 | The Board Of Regents Of The University Nebraska | N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis |
| CN1649614A (zh) | 2002-02-22 | 2005-08-03 | 新河药品股份有限公司 | 活性剂传递系统和保护及施用活性剂的方法 |
| WO2008095221A1 (fr) | 2007-02-07 | 2008-08-14 | Gosforth Centre (Holdings) Pty Ltd | Traitement du syndrome hypercinétique |
| EP2331088A4 (fr) | 2008-08-06 | 2011-10-12 | Gosforth Ct Holdings Pty Ltd | Compositions et procédés de traitement de troubles psychiatriques |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU639722B2 (en) * | 1989-10-27 | 1993-08-05 | Astra Aktiebolag | Use of arylalkylamides in the treatment of neurodegenerative diseases |
| DE3940410A1 (de) * | 1989-12-04 | 1991-06-06 | Schering Ag | Neue verwendung von nmda-rezeptor-antagonisten |
-
1992
- 1992-05-02 GB GB929209599A patent/GB9209599D0/en active Pending
-
1993
- 1993-04-30 CA CA002134783A patent/CA2134783C/fr not_active Expired - Fee Related
- 1993-04-30 DE DE69325512T patent/DE69325512T2/de not_active Expired - Fee Related
- 1993-04-30 DK DK93911903T patent/DK0637956T3/da active
- 1993-04-30 IL IL105569A patent/IL105569A/xx not_active IP Right Cessation
- 1993-04-30 JP JP51908793A patent/JP3542801B2/ja not_active Expired - Fee Related
- 1993-04-30 SG SG1996007583A patent/SG49202A1/en unknown
- 1993-04-30 ZA ZA933086A patent/ZA933086B/xx unknown
- 1993-04-30 ES ES93911903T patent/ES2135476T3/es not_active Expired - Lifetime
- 1993-04-30 EP EP93911903A patent/EP0637956B1/fr not_active Expired - Lifetime
- 1993-04-30 NZ NZ252728A patent/NZ252728A/en not_active IP Right Cessation
- 1993-04-30 NZ NZ299042A patent/NZ299042A/en not_active IP Right Cessation
- 1993-04-30 AT AT93911903T patent/ATE181669T1/de not_active IP Right Cessation
- 1993-04-30 KR KR1019940703908A patent/KR950701216A/ko not_active Application Discontinuation
- 1993-04-30 WO PCT/GB1993/000908 patent/WO1993021910A1/fr active IP Right Grant
-
1995
- 1995-06-23 HU HU95P/P00425P patent/HU211305A9/hu unknown
-
1999
- 1999-09-23 GR GR990402420T patent/GR3031320T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3031320T3 (en) | 1999-12-31 |
| DE69325512D1 (de) | 1999-08-05 |
| EP0637956A1 (fr) | 1995-02-15 |
| JP3542801B2 (ja) | 2004-07-14 |
| ES2135476T3 (es) | 1999-11-01 |
| DK0637956T3 (da) | 1999-11-22 |
| CA2134783C (fr) | 2002-08-13 |
| HU211305A9 (en) | 1995-11-28 |
| SG49202A1 (en) | 1998-05-18 |
| DE69325512T2 (de) | 1999-12-16 |
| KR950701216A (ko) | 1995-03-23 |
| WO1993021910A1 (fr) | 1993-11-11 |
| NZ252728A (en) | 1996-11-26 |
| GB9209599D0 (en) | 1992-06-17 |
| ZA933086B (en) | 1993-11-01 |
| EP0637956B1 (fr) | 1999-06-30 |
| CA2134783A1 (fr) | 1993-11-11 |
| NZ299042A (en) | 2000-07-28 |
| IL105569A0 (en) | 1993-08-18 |
| JPH07506105A (ja) | 1995-07-06 |
| ATE181669T1 (de) | 1999-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1003978A1 (en) | Composition for the treatment of schizophrenia | |
| IL108286A0 (en) | Use of anticonvulsants in the treatment of parkinson's disease and parkinsonian syndromes | |
| GB2288732B (en) | Pharmaceutical compositions | |
| HUT75089A (en) | Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| ZA892399B (en) | Pharmaceutical compositions of piroxicam in aqueous solution and process for their preparation | |
| DE59811768D1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
| IL105569A (en) | Pharmaceutical compositions containing remacemide for the treatment of parkinson's disease | |
| PL318130A1 (en) | Terpenod derivatives (of sarcodictyine)as antineoplastic agents | |
| HUT71838A (en) | Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions | |
| NZ268039A (en) | Use of efaroxan in treating parkinson's disease | |
| MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| IT1262567B (it) | Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia. | |
| TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases | |
| MY110416A (en) | Composition for the treatment of schizophrenia. | |
| IT1275987B1 (it) | Composizione farmaceutica attiva nella cura di affezioni dermatologiche |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |